RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Ikena Oncology Stock

Ikena Oncology Liabilities 2024

Ikena Oncology Liabilities

22.33 M USD

Ticker

IKNA

ISIN

US45175G1085

In 2024, Ikena Oncology's total liabilities amounted to 22.33 M USD, a -11.72% difference from the 25.3 M USD total liabilities in the previous year.

Ikena Oncology Aktienanalyse

What does Ikena Oncology do?

Ikena Oncology Inc is a biopharmaceutical company specializing in the development and research of drugs for the treatment of cancer. The company was founded in 2016 and is headquartered in Boston, Massachusetts. Ikena Oncology ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Ikena Oncology's Liabilities

Ikena Oncology's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Ikena Oncology's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Ikena Oncology's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Ikena Oncology's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Ikena Oncology’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Ikena Oncology stock

What is the level of liabilities of Ikena Oncology this year?

Ikena Oncology has a debt balance of 22.33 M USD this year.

What were the liabilities of Ikena Oncology compared to the previous year?

The liabilities of Ikena Oncology have increased by -11.72% dropped compared to the previous year.

What are the consequences of high debt for investors of Ikena Oncology?

High liabilities can pose a risk for investors of Ikena Oncology, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Ikena Oncology?

Low liabilities mean that Ikena Oncology has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Ikena Oncology affect the company?

An increase in liabilities of Ikena Oncology can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Ikena Oncology affect the company?

A decrease in the liabilities of Ikena Oncology can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Ikena Oncology?

Some factors that can influence the liabilities of Ikena Oncology include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Ikena Oncology so important for investors?

The liabilities of Ikena Oncology are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Ikena Oncology take to modify the liabilities?

To change its liabilities, Ikena Oncology can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Ikena Oncology pay?

Over the past 12 months, Ikena Oncology paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Ikena Oncology is expected to pay a dividend of 0 USD.

What is the dividend yield of Ikena Oncology?

The current dividend yield of Ikena Oncology is .

When does Ikena Oncology pay dividends?

Ikena Oncology pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Ikena Oncology?

Ikena Oncology paid dividends every year for the past 0 years.

What is the dividend of Ikena Oncology?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Ikena Oncology located?

Ikena Oncology is assigned to the '-' sector.

Wann musste ich die Aktien von Ikena Oncology kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Ikena Oncology from 11/1/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/1/2024.

When did Ikena Oncology pay the last dividend?

The last dividend was paid out on 11/1/2024.

What was the dividend of Ikena Oncology in the year 2023?

In the year 2023, Ikena Oncology distributed 0 USD as dividends.

In which currency does Ikena Oncology pay out the dividend?

The dividends of Ikena Oncology are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Ikena Oncology

Our stock analysis for Ikena Oncology Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Ikena Oncology Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.